Search Within

Shari Goldfarb

Formats
  1. Meeting Abstract (89)
  2. Journal Article (51)
  3. Book Section (4)
  4. Review (2)
  5. Correspondence (1)
  6. Miscellaneous (1)
Groups
  1. Breast Medicine Service (148)
  2. Department of Medicine (148)
  3. Epidemiology and Biostatistics (148)
  4. Health Outcomes Research Group (148)
  5. Population Sciences Research Program (148)
  6. Solid Tumor Oncology Division (148)

More Groups

People
  1. Maura Dickler (50)
  2. Jeanne Carter (37)
  3. Mario Lacouture (34)
  4. Sujata Patil (34)
  5. Clifford Hudis (31)
  6. Diana Lake (22)

More People

Years
  1. 2025 (1)
  2. 2024 (6)
  3. 2023 (8)
  4. 2022 (11)
  5. 2021 (9)
  6. 2020 (10)

More Years

Publications
  1. Journal of Clinical Oncology (36)
  2. Cancer Research (25)
  3. Journal of Sexual Medicine (12)
  4. Breast Cancer Research and Treatment (9)
  5. Annals of Surgical Oncology (8)
  6. Fertility and Sterility (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (37)
  2. American Association for Cancer Research (25)
  3. Elsevier Inc. (23)
  4. Springer (21)
  5. Elsevier Science, Inc. (7)
  6. Lippincott Williams & Wilkins (6)

More Publishers

Results (148)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Effects of lasofoxifene versus fulvestrant on vaginal and vulvar symptoms in patients with ESR1-mutated, ER+/HER2-, metastatic breast cancer from the ELAINE 1 study
    Journal Article

    Goldfarb, S. B.; Sammons, S. L.; Meisel, J. L.; Pluard, T. J.; Jenkins, S. N.; Komm, B. S.; Carroll, D.; Portman, D. J.
    Clinical Breast Cancer (2025)

    Fulltext@MSK | Save
  • Oral minoxidil for late alopecia in cancer survivors
    Journal Article

    Kuo, A. M. S.; Reingold, R. E.; Ketosugbo, K. F.; Pan, A.; Kraehenbuehl, L.; Dusza, S.; Gajria, D.; Lake, D. E.; Bromberg, J. F.; Traina, T. A.; more...
    Breast Cancer Research and Treatment (2024)

    Fulltext@MSK | Save
  • Improving chemotherapy-induced alopecia for women receiving anthracycline plus taxane chemotherapy using the Paxman scalp cooling system at lower temperatures
    Meeting Abstract

    Goldfarb, S. B.; Jamner, A.; Toumbacaris, N.; Gordon, A.; Chen, Y.; Abdo, N.; Dacunto, A.; Blinder, V. S.; Fornier, M. N.; Chang, C.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Quality of life in patients with malignant wounds treated at a wound care clinic
    Meeting Abstract

    Chen, A.; Dusza, S. W.; Bromberg, J.; Chandarlapaty, S.; Goldfarb, S. B.; Sanford, R. A.; Markova, A.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Flibanserin improves libido and sexual satisfaction in women with breast cancer on endocrine therapy
    Meeting Abstract

    Goldfarb, S.; Carter, J.; Toumbacaris, N.; Cheng, M.; Arkema, A.; Abdo, N.; Chang, C.; Wong, S.; Jamner, A.; Chen, Y.; more...
    Journal of Sexual Medicine (2024)

    Fulltext@MSK | Save
  • Validation and responsiveness of the English version of the Chemotherapy-Induced Alopecia Distress Scale (CADS) in breast cancer patients
    Journal Article

    Kraehenbuehl, L.; Kang, D.; Bang, A. S.; Ketosugbo, K. F.; Hay, J.; Patil, S.; Goldfarb, S.; Cho, J.; Lacouture, M. E.
    Supportive Care in Cancer (2024)

    Fulltext@MSK | Save
  • Selection of appropriate biomarkers to monitor effectiveness of ovarian function suppression in pre-menopausal patients with ER+ breast cancer
    Review

    McCann, K. E.; Goldfarb, S. B.; Traina, T. A.; Regan, M. M.; Vidula, N.; Kaklamani, V.
    npj Breast Cancer (2024)

    Fulltext@MSK | Save
  • Vaginal and vulvar symptoms in patients with ESR1-mutated, ER+/ HER2- metastatic breast cancer by baseline characteristics
    Meeting Abstract

    Goldfarb, S. B.; Sammons, S.; Meisel, J. L.; Pluard, T. J.; Jenkins, S. N.; Komm, B.; Carroll, D.; Portman, D. J.
    Menopause (2023)

    Fulltext@MSK | Save
  • Vaginal/vulvar symptoms with lasofoxifene versus fulvestrant in ESR1-Mutated, Er+/Her2-metastatic breast cancer patients
    Meeting Abstract

    Goldfarb, S. B.; Sammons, S. L.; Meisel, J. L.; Pluard, T. J.; Jenkins, S. N.; Komm, B.; Carroll, D.; Portman, D. J.
    Journal of Sexual Medicine (2023)

    Fulltext@MSK | Save
  • A prospective longitudinal analysis of the predictors of amenorrhea after breast cancer chemotherapy: Impact of BRCA pathogenic variants
    Journal Article

    Oktay, K. H.; Turan, V.; Bedoschi, G.; Abdo, N.; Bang, H.; Goldfarb, S.
    Cancer Medicine (2023)

    Fulltext@MSK | Save